{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T23:23:14Z","timestamp":1789687394816,"version":"4.0.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,28]],"date-time":"2023-12-28T00:00:00Z","timestamp":1703721600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["NMRC\/LCG\/0042018"],"award-info":[{"award-number":["NMRC\/LCG\/0042018"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ajo.2023.12.011","type":"journal-article","created":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T13:31:37Z","timestamp":1703079097000},"page":"121-131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Features Associated With Vision in Eyes With Subfoveal Fibrosis From Neovascular Age-Related Macular Degeneration"],"prefix":"10.1016","volume":"261","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7458-7081","authenticated-orcid":false,"given":"Kelvin Y.C.","family":"Teo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinzhi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farah Ilyana","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5356-7604","authenticated-orcid":false,"given":"Beau","family":"Fenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2606-3734","authenticated-orcid":false,"given":"Usha","family":"Chakravarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3358-3516","authenticated-orcid":false,"given":"Chui Ming Gemmy","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ajo.2023.12.011_bib0001","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ajo.2023.12.011_bib0002","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.preteyeres.2016.04.002","article-title":"Age-related macular degeneration and polypoidal choroidal vasculopathy in Asians","volume":"53","author":"Wong","year":"2016","journal-title":"Prog Retin Eye Res"},{"issue":"10","key":"10.1016\/j.ajo.2023.12.011_bib0003","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1001\/jamaophthalmol.2020.3001","article-title":"Associations of variation in retinal thickness with visual acuity and anatomic outcomes in eyes with neovascular age-related macular degeneration lesions treated with anti-vascular endothelial growth factor agents","volume":"138","author":"Evans","year":"2020","journal-title":"JAMA Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2023.12.011_bib0004","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1097\/IAE.0000000000002779","article-title":"Prevalence and risk factors for the development of physician-graded subretinal fibrosis in eyes treated for neovascular age-related macular degeneration","volume":"40","author":"Teo","year":"2020","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.ajo.2023.12.011_bib0005","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/IAE.0000000000003267","article-title":"The impact of disease activity on 5 year outcomes in patients undergoing treatment for neovascular age related macular degeneration","volume":"42","author":"Teo","year":"2022","journal-title":"Retina"},{"issue":"2","key":"10.1016\/j.ajo.2023.12.011_bib0006","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ophtha.2018.08.035","article-title":"Macular morphology and visual acuity in year five of the Comparison of Age-related Macular Degeneration Treatments Trials","volume":"126","author":"Jaffe","year":"2019","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ajo.2023.12.011_bib0007","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1136\/bjo.87.5.609","article-title":"Identification of lesion components that influence visual function in age related macular degeneration","volume":"87","author":"Hogg","year":"2003","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2023.12.011_bib0008","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ophtha.2013.10.019","article-title":"Risk of scar in the comparison of age-related macular degeneration treatments trials","volume":"121","author":"Daniel","year":"2014","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.ajo.2023.12.011_bib0009","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/j.ophtha.2016.03.045","article-title":"Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: the Comparison of Age-Related Macular Degeneration Treatments Trials","volume":"123","author":"Maguire","year":"2016","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ajo.2023.12.011_bib0010","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.oret.2017.08.019","article-title":"Tomographic biomarkers predicting progression to fibrosis in treated neovascular age-related macular degeneration: a multimodal imaging study","volume":"2","author":"Casalino","year":"2018","journal-title":"Ophthalmol Retina"},{"issue":"12","key":"10.1016\/j.ajo.2023.12.011_bib0011","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.oret.2019.06.002","article-title":"The evolution of fibrosis and atrophy and their relationship with visual outcomes in Asian persons with neovascular age-related macular degeneration","volume":"3","author":"Cheung","year":"2019","journal-title":"Ophthalmol Retina"},{"issue":"3","key":"10.1016\/j.ajo.2023.12.011_bib0012","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00441-021-03514-8","article-title":"Subretinal fibrosis in neovascular age-related macular degeneration: current concepts, therapeutic avenues, and future perspectives","volume":"387","author":"Tenbrock","year":"2022","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.ajo.2023.12.011_bib0013","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.exer.2015.03.009","article-title":"Molecular mechanisms of subretinal fibrosis in age-related macular degeneration","volume":"142","author":"Ishikawa","year":"2016","journal-title":"Exp Eye Res"},{"issue":"2","key":"10.1016\/j.ajo.2023.12.011_bib0014","doi-asserted-by":"crossref","first-page":"189","DOI":"10.18240\/ijo.2022.02.01","article-title":"Inhibitory effect on subretinal fibrosis by anti-placental growth factor treatment in a laser-induced choroidal neovascularization model in mice","volume":"15","author":"Zhang","year":"2022","journal-title":"Int J Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2023.12.011_bib0015","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/j.1442-9071.2012.02765.x","article-title":"Asian age-related macular degeneration phenotyping study: rationale, design and protocol of a prospective cohort study","volume":"40","author":"Cheung","year":"2012","journal-title":"Clin Exp Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2023.12.011_bib0016","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ophtha.2019.11.004","article-title":"Consensus nomenclature for reporting neovascular age-related macular degeneration data: Consensus on Neovascular Age-Related Macular Degeneration Nomenclature Study Group","volume":"127","author":"Spaide","year":"2020","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.ajo.2023.12.011_bib0017","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.oret.2023.06.024","article-title":"Hyperreflective material boundary remodeling in neovascular age-related macular degeneration: a post hoc analysis of the AVENUE Trial","volume":"7","author":"Yu","year":"2023","journal-title":"Ophthalmol Retina"},{"issue":"1","key":"10.1016\/j.ajo.2023.12.011_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s004170050034","article-title":"The effects of growth factors and conditioned media on the proliferation of human corneal epithelial cells and keratocytes","volume":"236","author":"Pancholi","year":"1998","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ajo.2023.12.011_bib0019","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.preteyeres.2012.10.002","article-title":"Immunological homeostasis of the eye","volume":"33","author":"Mochizuki","year":"2013","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.ajo.2023.12.011_bib0020","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.preteyeres.2018.10.003","article-title":"Immune regulation in the aging retina","volume":"69","author":"Chen","year":"2019","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"10.1016\/j.ajo.2023.12.011_bib0021","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3928\/15428877-20100924-01","article-title":"Development of subretinal fibrosis after anti-VEGF treatment in neovascular age-related macular degeneration","volume":"42","author":"Hwang","year":"2011","journal-title":"Ophthalmic Surg Lasers Imaging"},{"issue":"1","key":"10.1016\/j.ajo.2023.12.011_bib0022","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ajo.2013.02.012","article-title":"Subfoveal fibrosis in eyes with neovascular age-related macular degeneration treated with intravitreal ranibizumab","volume":"156","author":"Bloch","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2023.12.011_bib0023","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ajo.2023.03.033","article-title":"Ten-year incidence of fibrosis and risk factors for its development in neovascular age-related macular degeneration","volume":"252","author":"Romano","year":"2023","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2023.12.011_bib0024","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.ophtha.2017.11.019","article-title":"Polypoidal choroidal vasculopathy: definition, pathogenesis, diagnosis, and management","volume":"125","author":"Cheung","year":"2018","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.ajo.2023.12.011_bib0025","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1007\/s00417-015-2933-2","article-title":"The natural history of polypoidal choroidal vasculopathy: a multi-center series of untreated Asian patients","volume":"253","author":"Cheung","year":"2015","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939423005184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939423005184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T04:26:12Z","timestamp":1778646372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939423005184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":25,"alternative-id":["S0002939423005184"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2023.12.011","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Features Associated With Vision in Eyes With Subfoveal Fibrosis From Neovascular Age-Related Macular Degeneration","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2023.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}